Or Relapsed Cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-03-20
Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma [Phase 1, Phase 2]
A clinical trial update on ThisCART19A in patients with refractory or relapsed B cell lymphoma across Phase 1 and Phase 2, reporting on safe…